← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2008Last known activity
Jan 1, 2014
Defunct as of Oct 1, 2019
Timeline
2000s
- Jun 1, 2008
Cortice Biosciences, Inc.— Founded
2010s
- Oct 1, 2019
Cortice Biosciences, Inc.— Defunct
Drugs by trial phase (7 distinct, 14 trials)
Phase 2 (7 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT02047214Lead sponsorPhase 2Jan 1, 2014
- NCT01340729CollaboratorPhase 1/Phase 2Sep 1, 2013
- NCT01933815Lead sponsorPhase 1/Phase 2Aug 1, 2013
- NCT01582152CollaboratorPhase 1/Phase 2Jul 1, 2012
- NCT01505608CollaboratorPhase 1/Phase 2Dec 1, 2011
- NCT01483820CollaboratorPhase 1/Phase 2Dec 1, 2011
- NCT01332630CollaboratorPhase 2Aug 16, 2011
- NCT01113463CollaboratorPhase 2Apr 1, 2010
- NCT01067066CollaboratorPhase 1/Phase 2Feb 1, 2010
- NCT00867568CollaboratorPhase 1Mar 1, 2009
- NCT00553813Lead sponsorPhase 2Oct 1, 2007
- NCT00479635Lead sponsorPhase 2Jan 1, 2007
- NCT00256191Lead sponsorPhase 1Nov 1, 2005
- NCT00113724Lead sponsorPhase 1May 1, 2005
Details
- Founded
- New York, NY, US Jun 1, 2008
- Last known activity
- Jan 1, 2014